tirzepatide cause heart palpitations and UC Irvine researchers project cardiac benefits from weight-loss medication tirzepatide Tirzepatide 5 mg extremely high
Description
Follow meInstagram/ Feliciannurse Facebook Group/ GLP with Feliciannurse
If you were a white person visiting Mississippi in the summer of 1964, you were risking your life
Tell FDA leaders to put patient safety and evidence-based medicine first before the June 30, 2026 public comment deadline
Terzepatide is a new GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist that recently received FDA approval for treatment of Type 2 diabetes.
The move comes as the pharma industry has been experimenting with direct-to-consumer models in an effort to broaden access to in-demand drugs
